Julien Ogier

Julien Ogier is an accomplished professional in the field of clinical pharmacology and drug development, currently serving as Vice President and Head of Clinical Pharmacology, DMPK, and Pharmacometrics at Ipsen since March 2017. With a progressive career at Ipsen, Julien has held various leadership roles focused on managing teams, developing clinical pharmacology strategies, and ensuring compliance with regulatory standards for projects in oncology and rare diseases. Prior experience includes significant positions at Servier, where Julien was responsible for global strategy coordination in DMPK and clinical pharmacology for multiple programs. Educational credentials comprise a Ph.D. in Chemistry from Université Paris-Saclay and a Master of Science in Material Science from the University of New Hampshire, complemented by an engineering diploma in Organic Chemistry from Ecole Nationale Supérieure de Chimie de Montpellier. Julien is also partaking in the IPSEN Impact Together Program through IMD in early 2024.